首页> 外文期刊>Vascular and endovascular surgery >Reduction in allogeneic blood products with routine use of autotransfusion in open elective infrarenal abdominal aortic aneurysm repair
【24h】

Reduction in allogeneic blood products with routine use of autotransfusion in open elective infrarenal abdominal aortic aneurysm repair

机译:常规使用自体输血在开放性择期肾下腹主动脉瘤修复中减少异体血液制品

获取原文
获取原文并翻译 | 示例
           

摘要

Background and objectives: Concern about allogeneic blood product cost and complications has prompted interest in blood conservation techniques. Intraoperative autotransfusion (IAT) is currently not used routinely by vascular surgeons in open elective infrareanl abdominal aortic aneurysm (AAA) repair. The objective of this study is to review our experience with IAT and its impact on blood transfusion. Methods: We retrospectively reviewed the medical records of consecutive patients treated electively over a 4-year period and compared 2 strategy related to IAT, routine use IAT (rIAT) versus on-demand IAT (oIAT). Outcomes measured were number of units of allogeneic red blood cells and autologous red blood cells transfused intraoperatively and postoperatively, preoperative, postoperative, and discharge hemoglobin levels; postoperative infections; length of postoperative intensive care stay; and length of hospital stay. T-independent and Fisher exact test were used. Results: A total of 212 patients were included, 38 (18%) in the rIAT and 174 (82%) in the oIAT. Groups were similar except for an inferior creatinine and a superior mean aneurysm diameter for the rIAT group. Patients in the rIAT group had a lower rate of transfusion (26% vs 54%, P = .002) and a lower mean number of blood unit transfused (0.8 vs 1.8, P = .048). These findings were still more significant for AAA larger than 60 mm (18% rIAT vs 62% oIAT, P = .0001). Postoperative hemoglobin was superior in the rIAT group (107 vs 101 g/L, P = .01). Mean postoperative intensive care length of stay was shorter for the rIAT group (1.1 vs 1.8 days, P = .01). No difference was noted for infection, mortality, or hospital length of stay. Conclusion: The rIAT reduced the exposure to allogeneic blood products by more than 50%, in particular for patients with AAA larger than 60 mm. These results support the use of rIAT for open elective infrarenal AAA repair.
机译:背景与目的:对同种异体血液制品成本和并发症的关注促使人们对血液保存技术产生了兴趣。血管外科医生目前不经常在开放性择期下腹主动脉瘤(AAA)修复中常规使用术中自体输血(IAT)。这项研究的目的是回顾我们在IAT方面的经验及其对输血的影响。方法:我们回顾性回顾了连续四年接受选择性治疗的连续患者的病历,并比较了两种与IAT相关的策略:常规使用IAT(rIAT)与按需IAT(oIAT)。测量的结果是术中和术后,术前,术后和出院血红蛋白水平输注的同种异体红细胞和自体红细胞的数量;术后感染;术后重症监护时间和住院时间。使用非T依赖性和Fisher精确检验。结果:共纳入212例患者,其中rIAT患者38例(18%),oIAT患者174例(82%)。除rIAT组的肌酐较低和平均动脉瘤直径较大外,各组相似。 rIAT组患者的输血率较低(26%vs 54%,P = .002),平均输血单位数较低(0.8 vs 1.8,P = .048)。对于大于60 mm的AAA,这些发现仍然更为显着(rIAT为18%,oIAT为62%,P = .0001)。 rIAT组术后血红蛋白更好(107 vs 101 g / L,P = 0.01)。 rIAT组的平均术后重症监护病程较短(1.1 vs 1.8天,P = 0.01)。感染,死亡率或住院时间无差异。结论:rIAT将异体血液制品的暴露减少了50%以上,特别是对于AAA大于60 mm的患者。这些结果支持使用rIAT进行开放性择期肾下AAA修复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号